235 related articles for article (PubMed ID: 25554400)
1. [Psoriatic arthritis during rituximab treatment of granulomatosis with polyangiitis: a new paradoxical side effect?].
Aussy A; Girszyn N; Vandhuick T; Marie I; Vittecoq O; Lévesque H; Benhamou Y
Rev Med Interne; 2015 Jul; 36(7):491-4. PubMed ID: 25554400
[TBL] [Abstract][Full Text] [Related]
2. Rituximab as a new therapeutic option in granulomatosis with polyangiitis: a report of two cases.
Dalkilic E; Alkis N; Kamali S
Mod Rheumatol; 2012 Jun; 22(3):463-6. PubMed ID: 21847703
[TBL] [Abstract][Full Text] [Related]
3. [Paradoxical cutaneous reactions associated with tocilizumab therapy].
Sparsa L; Afif N; Bularca S; Fricker A; Thiebault S; Dahan E; Wendling D; Sibilia J; Ardizzone M
Rev Med Interne; 2014 Sep; 35(9):613-6. PubMed ID: 24630585
[TBL] [Abstract][Full Text] [Related]
4. Lower doses of rituximab in remission induction for refractory granulomatosis with polyangiitis.
Wawrzycka-Adamczyk K; Zugaj A; Włudarczyk A; Kosałka J; Sznajd J; Bazan-Socha S; Musiał J
Przegl Lek; 2014; 71(12):663-5. PubMed ID: 25951692
[TBL] [Abstract][Full Text] [Related]
5. Rituximab in the treatment of refractory scleritis in patients with granulomatosis with polyangiitis (Wegener's).
Recillas-Gispert C; Serna-Ojeda JC; Flores-Suárez LF
Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2279-84. PubMed ID: 26507398
[TBL] [Abstract][Full Text] [Related]
6. [Granulomatosis with polyangiitis (previously Wegener's granulomatosis) mimicking malingering].
Ene N; Bélénotti P; Benyamine A; Sovaila S; Ben Sahla Talet MH; Kaminsky P; Serratrice J; Weiller PJ
Rev Med Interne; 2014 Aug; 35(8):540-2. PubMed ID: 23886885
[TBL] [Abstract][Full Text] [Related]
7. Rituximab-induced Acute Thrombocytopenia in Granulomatosis with Polyangiitis.
Endo Y; Koga T; Ishida M; Fujita Y; Tsuji S; Takatani A; Shimizu T; Sumiyoshi R; Igawa T; Umeda M; Fukui S; Nishino A; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Kawakami A
Intern Med; 2018 Aug; 57(15):2247-2250. PubMed ID: 29526948
[TBL] [Abstract][Full Text] [Related]
8. Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab.
Geetha D; Kallenberg C; Stone JH; Salama AD; Appel GB; Duna G; Brunetta P; Jayne D
J Nephrol; 2015 Feb; 28(1):17-27. PubMed ID: 25185728
[TBL] [Abstract][Full Text] [Related]
9. Granulomatosis with polyangiitis (Wegener's granulomatosis) with hard palate and bronchial perforations treated with rituximab - a case report.
Kosałka J; Bazan-Socha S; Zugaj A; Ignacak M; Zuk J; Sokołowska B; Musiał J
Pneumonol Alergol Pol; 2014; 82(5):454-7. PubMed ID: 25133814
[TBL] [Abstract][Full Text] [Related]
10. Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis.
Brogan P; Yeung RSM; Cleary G; Rangaraj S; Kasapcopur O; Hersh AO; Li S; Paripovic D; Schikler K; Zeft A; Bracaglia C; Eleftheriou D; Pordeli P; Melega S; Jamois C; Gaudreault J; Michalska M; Brunetta P; Cooper JC; Lehane PB;
Arthritis Rheumatol; 2022 Jan; 74(1):124-133. PubMed ID: 34164952
[TBL] [Abstract][Full Text] [Related]
11. Granulomatosis With Polyangiitis Presenting as Gastric Ulcer: An Unusual Initial Manifestation Successfully Treated With Rituximab.
Malik M; Ismail M; Pattanaik D
Am J Med Sci; 2015 Oct; 350(4):338-9. PubMed ID: 26191640
[No Abstract] [Full Text] [Related]
12. Rituximab as an effective and probably safe treatment for granulomatosis with polyangiitis (Wegener's Granulomatosis).
Tavakolpour S; Alesaeidi S
Int Immunopharmacol; 2019 May; 70():67-68. PubMed ID: 30785092
[No Abstract] [Full Text] [Related]
13. [Successful treatment of a patient with refractory Wegener's granulomatosis by rituximab].
Minami R; Miyamura T; Watanabe H; Takahama S; Yamamoto M; Suematsu E
Nihon Rinsho Meneki Gakkai Kaishi; 2007 Apr; 30(2):133-8. PubMed ID: 17473516
[TBL] [Abstract][Full Text] [Related]
14. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D
Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574
[TBL] [Abstract][Full Text] [Related]
15. Visceral disseminated varicella zoster virus infection after rituximab treatment for granulomatosis with polyangiitis.
Tsuji H; Yoshifuji H; Fujii T; Matsuo T; Nakashima R; Imura Y; Yukawa N; Ohmura K; Sumiyoshi S; Mimori T
Mod Rheumatol; 2017 Jan; 27(1):155-161. PubMed ID: 25159158
[TBL] [Abstract][Full Text] [Related]
16. Rituximab (MABTHERA) and severe polyangiitis. An option for patients informed of the uncertainties.
Prescrire Int; 2015 Jun; 24(161):145-8. PubMed ID: 26436161
[TBL] [Abstract][Full Text] [Related]
17. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
[TBL] [Abstract][Full Text] [Related]
18. Healing of leg ulcers associated with granulomatosis with polyangiitis (Wegener granulomatosis) after rituximab therapy.
Kindle S; Fanciullo J
Cutis; 2017 Jan; 99(1):E12-E15. PubMed ID: 28207017
[No Abstract] [Full Text] [Related]
19. Serum immunoglobulin levels and risk factors for hypogammaglobulinaemia during long-term maintenance therapy with rituximab in patients with granulomatosis with polyangiitis.
Besada E; Koldingsnes W; Nossent JC
Rheumatology (Oxford); 2014 Oct; 53(10):1818-24. PubMed ID: 24831059
[TBL] [Abstract][Full Text] [Related]
20. Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event.
Berger JR; Malik V; Lacey S; Brunetta P; Lehane PB
J Neurovirol; 2018 Jun; 24(3):323-331. PubMed ID: 29508305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
